Norris Medicines

quarterly
yearly
ParticularsDec '22Mar '23Jun '23Sep '23Dec '23
Revenue3.161.220.952.560.65
Expenses3.371.211.573.040.92
EBITDA0.340.56-0.39-0.25-0.04
EBIT0.190.38-0.52-0.39-0.18
Profit Before Tax-0.200.02-0.61-0.48-0.27
Net Profit-0.20-0.54-0.61-0.48-0.27
Financial Ratios
Operating Profit Margin10.76%46.28%-41.05%-9.77%-6.15%
Net Profit Margin-6.33%-44.63%-64.21%-18.75%-41.54%
Earning Per Share (Diluted)-0.20-0.54-0.61-0.48-0.27
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.8.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ